These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10642222)

  • 61. [The BCTRIMS Expanded Consensus on treatment of multiple sclerosis: III. Evidence and recommendation-based guidelines].
    Lana-Peixoto MA; Callegaro D; Moreira MA; Campos GB; Marchiori PE; Gabbai AA; Bacheschi LA; Arruda WO; Gama PD; Melo AS; Rocha FC; Lino AM; Ferreira ML; Ataide L;
    Arq Neuropsiquiatr; 2002 Sep; 60(3-B):881-6. PubMed ID: 12364967
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Venom therapy in multiple sclerosis.
    Mirshafiey A
    Neuropharmacology; 2007 Sep; 53(3):353-61. PubMed ID: 17583756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Mitoxantrone for the treatment of patients with multiple sclerosis].
    Komori M; Kondo T; Tanaka M
    Brain Nerve; 2009 May; 61(5):575-80. PubMed ID: 19514518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity.
    Gonsette RE; Dubois B
    J Neurol Sci; 2004 Aug; 223(1):81-6. PubMed ID: 15261566
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Drug therapy in multiple sclerosis].
    Le Page E; Edan G
    Rev Prat; 2006 Jun; 56(12):1336-46. PubMed ID: 16948222
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination therapy in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
    Neuhaus O; Hartung HP
    Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MS treatment: postmarketing studies.
    Montalban X
    J Neurol Sci; 2007 Aug; 259(1-2):42-5. PubMed ID: 17383679
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
    Bolton C
    Inflammopharmacology; 2007 Oct; 15(5):183-7. PubMed ID: 17943249
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug companies seek MS patients to lobby for new products.
    Yamey G
    BMJ; 2000 Jan; 320(7229):207. PubMed ID: 10642222
    [No Abstract]   [Full Text] [Related]  

  • 73. [Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
    Kling A; Dahlqvist R
    Lakartidningen; 2007 Jan 17-23; 104(3):128-30. PubMed ID: 17302117
    [No Abstract]   [Full Text] [Related]  

  • 74. Antigen-specific therapies in multiple sclerosis.
    Giacomini PS; Bar-Or A
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):551-60. PubMed ID: 19708820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G; Wipfler P; Ladurner G; Kraus J
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multiple sclerosis: pharmacogenomics and personalised drug treatment.
    Annibali V; Ristori G; Cannoni S; Romano S; Visconti A; Ghazaryan A; Figà Talamanca L; Salvetti M; Mechelli R
    Neurol Sci; 2006 Sep; 27 Suppl 5():S347-9. PubMed ID: 16998717
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.